DE60101468D1 - Direktkomprimierte partikel für feste darreichungsformen - Google Patents

Direktkomprimierte partikel für feste darreichungsformen

Info

Publication number
DE60101468D1
DE60101468D1 DE60101468T DE60101468T DE60101468D1 DE 60101468 D1 DE60101468 D1 DE 60101468D1 DE 60101468 T DE60101468 T DE 60101468T DE 60101468 T DE60101468 T DE 60101468T DE 60101468 D1 DE60101468 D1 DE 60101468D1
Authority
DE
Germany
Prior art keywords
directly compressed
pharmaceutical forms
compressed particles
copolymer
fixed pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60101468T
Other languages
English (en)
Other versions
DE60101468T2 (de
Inventor
R Wilber
Jian-Hwa Guo
S Greenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lubrizol Advanced Materials Inc
Original Assignee
Noveon IP Holdings Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noveon IP Holdings Corp filed Critical Noveon IP Holdings Corp
Application granted granted Critical
Publication of DE60101468D1 publication Critical patent/DE60101468D1/de
Publication of DE60101468T2 publication Critical patent/DE60101468T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
DE60101468T 2000-04-27 2001-04-17 Direktkomprimierte partikel für feste darreichungsformen Expired - Lifetime DE60101468T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US559687 1990-07-30
US09/559,687 US6623756B1 (en) 2000-04-27 2000-04-27 Directly compressed solid dosage articles
PCT/US2001/012400 WO2001082894A2 (en) 2000-04-27 2001-04-17 Directly compressed solid dosage particles

Publications (2)

Publication Number Publication Date
DE60101468D1 true DE60101468D1 (de) 2004-01-22
DE60101468T2 DE60101468T2 (de) 2004-10-28

Family

ID=24234605

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60101468T Expired - Lifetime DE60101468T2 (de) 2000-04-27 2001-04-17 Direktkomprimierte partikel für feste darreichungsformen

Country Status (13)

Country Link
US (1) US6623756B1 (de)
EP (1) EP1276466B1 (de)
JP (1) JP2003531848A (de)
CN (1) CN1195498C (de)
AT (1) ATE255886T1 (de)
BR (1) BR0110287A (de)
CA (1) CA2407140A1 (de)
DE (1) DE60101468T2 (de)
ES (1) ES2211796T3 (de)
IL (2) IL152461A0 (de)
MX (1) MXPA02010437A (de)
WO (1) WO2001082894A2 (de)
ZA (1) ZA200208571B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US6955821B2 (en) 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US6623754B2 (en) * 2001-05-21 2003-09-23 Noveon Ip Holdings Corp. Dosage form of N-acetyl cysteine
US20030012820A1 (en) * 2001-06-12 2003-01-16 Upadhyay Ajay Hasmukhlal Compressible guaifenesin compositions, method for making same and method for making compressed guaifenesin dosage forms therefrom
US6705028B2 (en) * 2001-09-12 2004-03-16 Honda Giken Kogyo Kabushiki Kaisha Self-propelled snowplow vehicle
US20040185016A1 (en) * 2002-07-30 2004-09-23 Popp Karl F Compositions for treatment of hyperpigmentation and methods for making and using such compositions
US20040219210A1 (en) * 2003-05-01 2004-11-04 Jian-Hwa Guo Controlled release solid dosage nifedipine formulations
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
US7704522B2 (en) * 2004-09-08 2010-04-27 Clyde Morgan Topical medicament
US20070077297A1 (en) * 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
FI20080353A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi erittäin korkean lääkepitoisuuden tabletin valmistamiseksi
FI20080346A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi lisäaineita sisältävän tabletin valmistamiseksi
FI20080355A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi metforminia käsittävien tablettien valmistamiseksi
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
CN101467988B (zh) * 2007-12-27 2014-07-09 北京德众万全医药科技有限公司 一种含有氨酚伪麻的药用组合物及其制备方法
US20110284573A1 (en) * 2008-12-17 2011-11-24 Allan Dagsland Method of providing a target dose, powder provider device and its use
WO2011017389A1 (en) 2009-08-05 2011-02-10 Idenix Pharmaceuticals, Inc. Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv
WO2011056764A1 (en) 2009-11-05 2011-05-12 Ambit Biosciences Corp. Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
AR079528A1 (es) 2009-12-18 2012-02-01 Idenix Pharmaceuticals Inc Inhibidores de arileno o heteroarileno 5,5-fusionado del virus de la hepatitis c
WO2011094890A1 (en) 2010-02-02 2011-08-11 Argusina Inc. Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
WO2011112689A2 (en) 2010-03-11 2011-09-15 Ambit Biosciences Corp. Saltz of an indazolylpyrrolotriazine
WO2012030913A1 (en) 2010-09-01 2012-03-08 Ambit Biosciences Corporation An optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
EP2611792B1 (de) 2010-09-01 2017-02-01 Ambit Biosciences Corporation Hydrobromid salze einer pyrazolylaminoquinazolin
AU2011338530B2 (en) 2010-12-06 2017-06-15 Follica, Inc. Methods for treating baldness and promoting hair growth
WO2012080050A1 (en) 2010-12-14 2012-06-21 F. Hoffmann-La Roche Ag Solid forms of a phenoxybenzenesulfonyl compound
JP2014503597A (ja) 2011-01-31 2014-02-13 セルジーン コーポレイション シチジンアナログの医薬組成物及びその使用方法
US9353100B2 (en) 2011-02-10 2016-05-31 Idenix Pharmaceuticals Llc Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections
US20120252721A1 (en) 2011-03-31 2012-10-04 Idenix Pharmaceuticals, Inc. Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
US8916555B2 (en) 2012-03-16 2014-12-23 Axikin Pharmaceuticals, Inc. 3,5-diaminopyrazole kinase inhibitors
NZ631142A (en) 2013-09-18 2016-03-31 Axikin Pharmaceuticals Inc Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
EP3046924A1 (de) 2013-09-20 2016-07-27 IDENIX Pharmaceuticals, Inc. Inhibitoren des hepatitis-c-virus
US20170066779A1 (en) 2014-03-05 2017-03-09 Idenix Pharmaceuticals Llc Solid forms of a flaviviridae virus inhibitor compound and salts thereof
CA2943231C (en) 2014-03-20 2023-10-24 Capella Therapeutics, Inc. Benzimidazole derivatives as erbb tyrosine kinase inhibitors for the treatment of cancer
US10005765B2 (en) 2014-03-20 2018-06-26 Capella Therapeutics, Inc. Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer
HUE049801T2 (hu) 2014-12-23 2020-10-28 Sma Therapeutics Inc 3,5-diaminopirazol kináz inhibitorok
WO2017062997A1 (en) 2015-10-09 2017-04-13 Reckitt Benckiser Llc Pharmaceutical formulation
JP2022520011A (ja) 2019-01-24 2022-03-28 ノヴォ ノルディスク アー／エス ローラコンパクタおよびローラコンパクタを使用する乾式造粒の方法
WO2021043971A1 (en) 2019-09-06 2021-03-11 Novo Nordisk A/S Method and equipment for fractionation of granules for use in pharmaceutical compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798053A (en) * 1952-09-03 1957-07-02 Goodrich Co B F Carboxylic polymers
US3915921A (en) * 1974-07-02 1975-10-28 Goodrich Co B F Unsaturated carboxylic acid-long chain alkyl ester copolymers and tri-polymers water thickening agents and emulsifiers
US4267103A (en) * 1978-12-07 1981-05-12 The B. F. Goodrich Company Solvent polymerization of carboxyl containing monomers
DE3888520T2 (de) * 1988-03-30 1994-07-21 Japan Synthetic Rubber Co Ltd Hoch vernetzte Polymerteilchen und Verfahren zur Herstellung derselben.
ATE209228T1 (de) 1992-05-09 2001-12-15 Surfachem Group Ltd Umwandlung von pulverförmigen polymeren
US5288814A (en) * 1992-08-26 1994-02-22 The B. F. Goodrich Company Easy to disperse polycarboxylic acid thickeners
US5780055A (en) * 1996-09-06 1998-07-14 University Of Maryland, Baltimore Cushioning beads and tablet comprising the same capable of forming a suspension

Also Published As

Publication number Publication date
DE60101468T2 (de) 2004-10-28
ATE255886T1 (de) 2003-12-15
IL152461A (en) 2007-08-19
ZA200208571B (en) 2003-08-19
IL152461A0 (en) 2003-05-29
CN1426297A (zh) 2003-06-25
CN1195498C (zh) 2005-04-06
WO2001082894A2 (en) 2001-11-08
EP1276466A2 (de) 2003-01-22
BR0110287A (pt) 2003-02-18
CA2407140A1 (en) 2001-11-08
ES2211796T3 (es) 2004-07-16
JP2003531848A (ja) 2003-10-28
US6623756B1 (en) 2003-09-23
EP1276466B1 (de) 2003-12-10
WO2001082894A3 (en) 2002-02-21
MXPA02010437A (es) 2003-04-25

Similar Documents

Publication Publication Date Title
DE60101468D1 (de) Direktkomprimierte partikel für feste darreichungsformen
EP2258345A3 (de) Feste pharmazeutische Dosierform enthaltende eine HIV Protease Inhibitor feste Dispersion
WO2006035417A3 (en) Dihydropyrimidine microcapsule - formulations
MX9701465A (es) Formulacion de acetaminofeno, de liberacion sostenida.
CA2385890A1 (en) Controlled release compositions comprising nimesulide
DK0869772T3 (da) Bioadhæsiv fast doseringsform
SI1476138T1 (sl) Formulacije s prirejenim sproščanjem vsaj ene oblike tramadola
MY169471A (en) Controlled release preparation
UA42062C2 (uk) Трифазова фармацевтична форма з постійним і контрольованим виділенням аморфного активного інгредієнта та спосіб її виготовлення
NO20064094L (no) Partikler
AU2003274681A1 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
MEP46008A (en) Solid pharmaceutical formulations comprising telmisartan
WO2003103637A3 (en) MODIFIED RELEASE MULTIPLE UNIT DRUG DELIVERY SYSTEMS
UA84266C2 (uk) Дозована лікарська форма у вигляді таблетки або пелети для перорального введення, яка містить інгібітор pde 4 та полівінілпіролідон, способи її одержання та застосування
CA2152795A1 (en) Readily available konjac glucomannan sustained release excipient
WO2002089773A3 (en) Pharmaceutical compositions comprising cyclosporin
NO20060445L (no) Fast farmasoytisk preparat omfattende amisulprid
CA2445519A1 (en) Method for manufacturing a low dose pharmaceutical composition
PT1195160E (pt) Composições farmacêuticas de trimetazidina de libertação sustentada e método para a sua preparação
WO2005123045A3 (en) Controlled release matrix pharmaceutical dosage formulation
WO2005115346A3 (en) Pharmaceutical composition containing risperidone
ZA200506992B (en) Fibrate tablet and method for the production thereof
ATE237316T1 (de) Ibuprofen und domperidone enthaltende pharmazeutische zusammensetzungen
ES2174734A1 (es) Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones.
CA2454449C (en) Synergistic filler composition of pvp-va and silicified mycrocrystalline cellulose for tablet dosage form

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee
8370 Indication related to discontinuation of the patent is to be deleted
8327 Change in the person/name/address of the patent owner

Owner name: LUBRIZOL ADVANCED MATERIALS, INC., CLEVELAND, , US